C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/02/2002	EP0716689B1 Process for producing and breeding haematopoetic precursor cells
10/02/2002	EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
10/02/2002	EP0600930B1 Diagnosis and treatment of autoimmune diseases
10/02/2002	DE10112109A1 Zellkultursubstrat und seine Verwendung Cell culture substrate and its use
10/02/2002	DE10111682A1 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use
10/02/2002	DE10109147A1 Verpackungszelllinie für lentivirale Vektoren Packaging cell line for lentiviral vectors
10/02/2002	CN1372599A Plant sterol acryltransferases
10/02/2002	CN1372592A Carrier for animal cell culture comprising organ tissue slice and animal cell culture method and transplantation method with the use of the carrier
10/02/2002	CN1372569A Keratinocyte growth factor-2
10/02/2002	CN1371991A Culture cell of Rhaphiolepis umbellata and method for culturing tissue using said cell
10/02/2002	CN1091780C Process for preparing macroreticular microcarrier without emulsifier
10/02/2002	CN1091764C Pesticidal sulfur compounds
10/02/2002	CN1091571C Fast Diyongjinlian trollius propagating technology
10/01/2002	US6458944 Human BMP-4 promoter and method for exploring bone-related substance by using the same
10/01/2002	US6458943 hD54 polynucleotides
10/01/2002	US6458937 Glycoconjugates and methods
10/01/2002	US6458934 Grafted complementarity determining regions to mouse monoclonal antibodies; amino acid replacements; autoimmune disease treatment and immunosuppressants; side effect reduction
10/01/2002	US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002	US6458593 Transfecting pituitary or follicular stellate cells with oncogene; controlling cellular differentiation and/or proliferation
10/01/2002	US6458592 Transfecting antibody-producing cell with homology-targeting vector with lox site; genetic engineering and expression
10/01/2002	US6458589 Hepatocyte lineage cells derived from pluripotent stem cells
10/01/2002	US6458588 Renal stem cells and uses thereof
10/01/2002	US6458587 Transfecting cells with a recombinant adeno-associated virus (aav) which can be package into infectious aav virions, a helper aav vector essential for replication and packaging and a productive vector which cannot be packaged into the virion
10/01/2002	US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering
10/01/2002	US6458585 Cytokine-free culture of dendritic cells
10/01/2002	US6458578 Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B
10/01/2002	US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences
10/01/2002	US6458567 Hepatitis C Virus ribozymes
10/01/2002	US6458565 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers
10/01/2002	US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation
10/01/2002	US6458563 Dna which encodes protein of defined amino acid sequence; stable, less immunogenic treatment of hemophilia
10/01/2002	US6458529 Assays for promoter operability in central nervous system cells
10/01/2002	US6458381 Lipids and their use, for example, in liposomes
10/01/2002	US6458369 Composition comprising tumor cells and extracts and method of using thereof
10/01/2002	US6458366 Compounds and methods for diagnosis of tuberculosis
10/01/2002	US6458364 Non-splicing variants of gp350/220
10/01/2002	US6458362 Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes
10/01/2002	US6458360 Soluble complement regulatory molecules
10/01/2002	US6458358 Compounds encoding the protective M-like protein of Streptococcus equi and assays therefor
10/01/2002	US6458356 Antibody-induced apoptosis
10/01/2002	US6458353 Anti-CCR2 antibodies and methods of use therefor
10/01/2002	US6458350 ULBP DNA and polypeptides
10/01/2002	US6458349 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing
10/01/2002	CA2281895C Ikb kinases
10/01/2002	CA2119930C Production of chimeric antibodies - a combinatorial approach
10/01/2002	CA2103546C Modified factor vii
10/01/2002	CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
10/01/2002	CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection
10/01/2002	CA1341389C Human granulocyte colony stimulating factor
09/2002
09/26/2002	WO2002075507A2 Anti-bacterial vaccine compositions
09/26/2002	WO2002075302A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal
09/26/2002	WO2002075275A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof
09/26/2002	WO2002074986A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies
09/26/2002	WO2002074980A2 Muteins of hypoxia inducible factor alpha and methods of use thereof
09/26/2002	WO2002074979A2 Expression profiles and methods of use
09/26/2002	WO2002074969A2 Matrix attachment regions and methods for use thereof
09/26/2002	WO2002074968A1 Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof
09/26/2002	WO2002074967A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof
09/26/2002	WO2002074965A2 Characterization of the i-spoml endonuclease from fission yeast
09/26/2002	WO2002074964A2 Polypeptides derived from rna polymerases and use thereof
09/26/2002	WO2002074959A2 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1
09/26/2002	WO2002074956A2 Dopaminergic neuronal survival-promoting factors and uses thereof
09/26/2002	WO2002074946A2 Method for generating insulin-secreting cells suitable for transplantation
09/26/2002	WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
09/26/2002	WO2002074937A1 Method of differentiating immature liver cells by using extracellular matrix
09/26/2002	WO2002074936A1 A stem cell manufacturing system
09/26/2002	WO2002074926A2 Myo-inositol oxygenases
09/26/2002	WO2002074925A2 Methods for identifying and purifying smooth muscle progenitor cells
09/26/2002	WO2002074921A2 Methods for isolating proteins expressed by dendritic cells
09/26/2002	WO2002074913A2 Nucleic acid-associated proteins
09/26/2002	WO2002074912A2 Tissue engineering enhanced by the transfer of a growth factor gene
09/26/2002	WO2002074902A2 Coculture of neurons with target cells in a bi-compartmented chamber
09/26/2002	WO2002074900A1 Culture system for embryos
09/26/2002	WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins
09/26/2002	WO2002074806A2 New interferon beta-like molecules
09/26/2002	WO2002074805A1 Soluble rage protein
09/26/2002	WO2002074798A2 The genome of a bifidobacterium
09/26/2002	WO2002074796A2 Histidine phosphatase interacting protein with 240kd
09/26/2002	WO2002074345A2 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
09/26/2002	WO2002074338A1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells
09/26/2002	WO2002074239A2 Compositions and methods for the treatment and clinical remission of psoriasis
09/26/2002	WO2002074158A2 Two-phase processing of thermosensitive polymers for use as biomaterials
09/26/2002	WO2002074157A2 A mammalian immortalized liver cell
09/26/2002	WO2002074048A2 P-glycoproteins and uses thereof
09/26/2002	WO2002074045A2 Production of pancreatic islet cells and delivery of insulin
09/26/2002	WO2002062999A8 Proteins and nucleic acids encoding same
09/26/2002	WO2002062957A3 Ter sites and ter binding proteins
09/26/2002	WO2002061420A3 Vitro in a cell interaction culture system for testing and developing medicaments
09/26/2002	WO2002053581A3 Spliceosome mediated rna trans-splicing
09/26/2002	WO2002053193A3 Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
09/26/2002	WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus
09/26/2002	WO2002042767A3 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium
09/26/2002	WO2002040501A3 Membrane scaffold proteins
09/26/2002	WO2002038609A3 Apolipoprotein conjugates
09/26/2002	WO2002032461A3 Protein c or activated protein c-like molecules
09/26/2002	WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation
09/26/2002	WO2002031155A3 Gene cluster for ramoplanin biosynthesis
09/26/2002	WO2002029084A3 Industrial-scale serum-free production of recombinant factor vii in mammalian cells
09/26/2002	WO2002026954A3 Truncated phosphodiesterase-7 polypeptides
09/26/2002	WO2002022656A3 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof

1 ... 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 ... 1827